GLORIA - Comparing the effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis

Academic head of project management: Zoltán Szekanecz

  • Title of project: GLORIA - A további alacsony dózisú glükokortikoid hatékonyságának és biztonságosságának összehasonlítása a reumatoid artritiszben szenvedő idős betegek kezelési stratégiáiban
  • Type of grant: H2020
  • Description: The objective of the project is to prove that the complementation of the current therapy treating rheumatism with chronic low-dose glucocorticoids (GC) is extremely cost effective and safe in the case of elderly patients with rheumatoid arthritis.
  • The duration of the project: September 1, 2015 – August 31, 2020
  • Actual total cost: 203.095 (EUR)
  • Type of research: Experimental
  • Consortium details:
    • Lead applicant: Stichting VU-VUmc
    • Consortium partner:
      • UNIVERSITA DEGLI STRUDI DI GENOVA (UNIGE)
      • Stichting Tools
      • BLUEPHARMA - INDUSTRIA FARMACEUTICASA (BLUEPHARMA)
      • ASSIGN BENELUX DEVELOPMENT BV (ABD)
      • CLINQUEST SERVICES BV (Clinquest Services B.V.)
      • QOLPAC BV (QOLPAC BV)
      • UNIVERSITATEA DE MEDICINA SI FARMACIE'CAROL DAVILA' DIN BUCURESTI
      • NARODNY USTAV REUMATICKYCH CHOROB-NURCH NIRD NATIONAL INSTITUTE OF RHEUMATIC DISEASES (NURCH NIRD)
      • CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA E.P.E (CHUC, E.P.E)
      • Charité - Universitätsmedizin Berlin
      • Debreceni Egyetem

Updated: 2017.08.15.


Dear User!

 

The University of Debrecen considers the protection of personal data and the information provided to be of paramount importance. We hereby inform you that the University of Debrecen has reviewed its processes and incorporated the requirements of GDPR into his own data management and data protection activities, which entered into force on may 25,2018. The personal data of the users has been carefully handled by the University of Debrecen, it complies with the applicable data management regulations.Following the requirements of GDPR, we updated our Privacy Statement, which you can access by clicking on the link below: Privacy Policy.